Herpes Zoster, also known as zoster or shingles, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide stripe either on the left or right side of the body or face. Two to four days before the rash occurs there may be tingling or local pain in the area. Otherwise there are typically few symptoms though some may have fever, headache, or feel tired. The rash usually heals within two to four weeks; however, some people develop ongoing nerve pain which can last for months or years, a condition called postherpetic neuralgia (PHN). In those with poor immune function the rash may occur widely. If the rash involves the eye, vision loss may occur.

Market Analysis and Insights: Global Herpes Zoster Treatment Market

The global Herpes Zoster Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Herpes Zoster Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Herpes Zoster Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Herpes Zoster Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Herpes Zoster Treatment include Roche, Novartis, Merck, GlaxoSmithKline, Abbott Laboratories, Astellas Pharma, Bausch Health Companies, Teva Pharmaceutical and Foamix Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Herpes Zoster Treatment is widely used in various fields, such as Hospitals, Clinics and Home Care Settings,, etc. Hospitals provides greatest supports to the Herpes Zoster Treatment industry development. In 2023, global % revenue of Herpes Zoster Treatment went into Hospitals filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Herpes Zoster Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Herpes Zoster Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Herpes Zoster Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Herpes Zoster Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Herpes Zoster Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Herpes Zoster Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Herpes Zoster Treatment Market Report

Report Metric	Details
Report Name	Herpes Zoster Treatment Market
Segment by Type	Oral Topical Others
Segment by Application	Hospitals Clinics Home Care Settings
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Novartis, Merck, GlaxoSmithKline, Abbott Laboratories, Astellas Pharma, Bausch Health Companies, Teva Pharmaceutical, Foamix Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Herpes Zoster Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Herpes Zoster Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Herpes Zoster Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Herpes Zoster Treatment Market report?

Ans: The main players in the Herpes Zoster Treatment Market are Roche, Novartis, Merck, GlaxoSmithKline, Abbott Laboratories, Astellas Pharma, Bausch Health Companies, Teva Pharmaceutical, Foamix Pharmaceuticals

What are the Application segmentation covered in the Herpes Zoster Treatment Market report?

Ans: The Applications covered in the Herpes Zoster Treatment Market report are Hospitals, Clinics, Home Care Settings

What are the Type segmentation covered in the Herpes Zoster Treatment Market report?

Ans: The Types covered in the Herpes Zoster Treatment Market report are Oral, Topical, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Herpes Zoster Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Oral

1.2.3 Topical

1.2.4 Others

1.3 Market by Application

1.3.1 Global Herpes Zoster Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Home Care Settings

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Herpes Zoster Treatment Market Perspective (2019-2030)

2.2 Global Herpes Zoster Treatment Growth Trends by Region

2.2.1 Herpes Zoster Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Herpes Zoster Treatment Historic Market Size by Region (2019-2024)

2.2.3 Herpes Zoster Treatment Forecasted Market Size by Region (2025-2030)

2.3 Herpes Zoster Treatment Market Dynamics

2.3.1 Herpes Zoster Treatment Industry Trends

2.3.2 Herpes Zoster Treatment Market Drivers

2.3.3 Herpes Zoster Treatment Market Challenges

2.3.4 Herpes Zoster Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Herpes Zoster Treatment by Players

3.1.1 Global Herpes Zoster Treatment Revenue by Players (2019-2024)

3.1.2 Global Herpes Zoster Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Herpes Zoster Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Herpes Zoster Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Herpes Zoster Treatment Market Concentration Ratio

3.4.1 Global Herpes Zoster Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Herpes Zoster Treatment Revenue in 2023

3.5 Global Key Players of Herpes Zoster Treatment Head office and Area Served

3.6 Global Key Players of Herpes Zoster Treatment, Product and Application

3.7 Global Key Players of Herpes Zoster Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Herpes Zoster Treatment Breakdown Data by Type

4.1 Global Herpes Zoster Treatment Historic Market Size by Type (2019-2024)

4.2 Global Herpes Zoster Treatment Forecasted Market Size by Type (2025-2030)

5 Herpes Zoster Treatment Breakdown Data by Application

5.1 Global Herpes Zoster Treatment Historic Market Size by Application (2019-2024)

5.2 Global Herpes Zoster Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Herpes Zoster Treatment Market Size (2019-2030)

6.2 North America Herpes Zoster Treatment Market Size by Type

6.2.1 North America Herpes Zoster Treatment Market Size by Type (2019-2024)

6.2.2 North America Herpes Zoster Treatment Market Size by Type (2025-2030)

6.2.3 North America Herpes Zoster Treatment Market Share by Type (2019-2030)

6.3 North America Herpes Zoster Treatment Market Size by Application

6.3.1 North America Herpes Zoster Treatment Market Size by Application (2019-2024)

6.3.2 North America Herpes Zoster Treatment Market Size by Application (2025-2030)

6.3.3 North America Herpes Zoster Treatment Market Share by Application (2019-2030)

6.4 North America Herpes Zoster Treatment Market Size by Country

6.4.1 North America Herpes Zoster Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Herpes Zoster Treatment Market Size by Country (2019-2024)

6.4.3 North America Herpes Zoster Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Herpes Zoster Treatment Market Size (2019-2030)

7.2 Europe Herpes Zoster Treatment Market Size by Type

7.2.1 Europe Herpes Zoster Treatment Market Size by Type (2019-2024)

7.2.2 Europe Herpes Zoster Treatment Market Size by Type (2025-2030)

7.2.3 Europe Herpes Zoster Treatment Market Share by Type (2019-2030)

7.3 Europe Herpes Zoster Treatment Market Size by Application

7.3.1 Europe Herpes Zoster Treatment Market Size by Application (2019-2024)

7.3.2 Europe Herpes Zoster Treatment Market Size by Application (2025-2030)

7.3.3 Europe Herpes Zoster Treatment Market Share by Application (2019-2030)

7.4 Europe Herpes Zoster Treatment Market Size by Country

7.4.1 Europe Herpes Zoster Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Herpes Zoster Treatment Market Size by Country (2019-2024)

7.4.3 Europe Herpes Zoster Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Herpes Zoster Treatment Market Size (2019-2030)

8.2 China Herpes Zoster Treatment Market Size by Type

8.2.1 China Herpes Zoster Treatment Market Size by Type (2019-2024)

8.2.2 China Herpes Zoster Treatment Market Size by Type (2025-2030)

8.2.3 China Herpes Zoster Treatment Market Share by Type (2019-2030)

8.3 China Herpes Zoster Treatment Market Size by Application

8.3.1 China Herpes Zoster Treatment Market Size by Application (2019-2024)

8.3.2 China Herpes Zoster Treatment Market Size by Application (2025-2030)

8.3.3 China Herpes Zoster Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Herpes Zoster Treatment Market Size (2019-2030)

9.2 Asia Herpes Zoster Treatment Market Size by Type

9.2.1 Asia Herpes Zoster Treatment Market Size by Type (2019-2024)

9.2.2 Asia Herpes Zoster Treatment Market Size by Type (2025-2030)

9.2.3 Asia Herpes Zoster Treatment Market Share by Type (2019-2030)

9.3 Asia Herpes Zoster Treatment Market Size by Application

9.3.1 Asia Herpes Zoster Treatment Market Size by Application (2019-2024)

9.3.2 Asia Herpes Zoster Treatment Market Size by Application (2025-2030)

9.3.3 Asia Herpes Zoster Treatment Market Share by Application (2019-2030)

9.4 Asia Herpes Zoster Treatment Market Size by Region

9.4.1 Asia Herpes Zoster Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Herpes Zoster Treatment Market Size by Region (2019-2024)

9.4.3 Asia Herpes Zoster Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Herpes Zoster Treatment Introduction

11.1.4 Roche Revenue in Herpes Zoster Treatment Business (2019-2024)

11.1.5 Roche Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Herpes Zoster Treatment Introduction

11.2.4 Novartis Revenue in Herpes Zoster Treatment Business (2019-2024)

11.2.5 Novartis Recent Developments

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Herpes Zoster Treatment Introduction

11.3.4 Merck Revenue in Herpes Zoster Treatment Business (2019-2024)

11.3.5 Merck Recent Developments

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Herpes Zoster Treatment Introduction

11.4.4 GlaxoSmithKline Revenue in Herpes Zoster Treatment Business (2019-2024)

11.4.5 GlaxoSmithKline Recent Developments

11.5 Abbott Laboratories

11.5.1 Abbott Laboratories Company Details

11.5.2 Abbott Laboratories Business Overview

11.5.3 Abbott Laboratories Herpes Zoster Treatment Introduction

11.5.4 Abbott Laboratories Revenue in Herpes Zoster Treatment Business (2019-2024)

11.5.5 Abbott Laboratories Recent Developments

11.6 Astellas Pharma

11.6.1 Astellas Pharma Company Details

11.6.2 Astellas Pharma Business Overview

11.6.3 Astellas Pharma Herpes Zoster Treatment Introduction

11.6.4 Astellas Pharma Revenue in Herpes Zoster Treatment Business (2019-2024)

11.6.5 Astellas Pharma Recent Developments

11.7 Bausch Health Companies

11.7.1 Bausch Health Companies Company Details

11.7.2 Bausch Health Companies Business Overview

11.7.3 Bausch Health Companies Herpes Zoster Treatment Introduction

11.7.4 Bausch Health Companies Revenue in Herpes Zoster Treatment Business (2019-2024)

11.7.5 Bausch Health Companies Recent Developments

11.8 Teva Pharmaceutical

11.8.1 Teva Pharmaceutical Company Details

11.8.2 Teva Pharmaceutical Business Overview

11.8.3 Teva Pharmaceutical Herpes Zoster Treatment Introduction

11.8.4 Teva Pharmaceutical Revenue in Herpes Zoster Treatment Business (2019-2024)

11.8.5 Teva Pharmaceutical Recent Developments

11.9 Foamix Pharmaceuticals

11.9.1 Foamix Pharmaceuticals Company Details

11.9.2 Foamix Pharmaceuticals Business Overview

11.9.3 Foamix Pharmaceuticals Herpes Zoster Treatment Introduction

11.9.4 Foamix Pharmaceuticals Revenue in Herpes Zoster Treatment Business (2019-2024)

11.9.5 Foamix Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bausch Health Companies

Teva Pharmaceutical

Foamix Pharmaceuticals

List of Tables

Table 1. Global Herpes Zoster Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Oral

Table 3. Key Players of Topical

Table 4. Key Players of Others

Table 5. Global Herpes Zoster Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Herpes Zoster Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Herpes Zoster Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Herpes Zoster Treatment Market Share by Region (2019-2024)

Table 9. Global Herpes Zoster Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Herpes Zoster Treatment Market Share by Region (2025-2030)

Table 11. Herpes Zoster Treatment Market Trends

Table 12. Herpes Zoster Treatment Market Drivers

Table 13. Herpes Zoster Treatment Market Challenges

Table 14. Herpes Zoster Treatment Market Restraints

Table 15. Global Herpes Zoster Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Herpes Zoster Treatment Revenue Share by Players (2019-2024)

Table 17. Global Top Herpes Zoster Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoster Treatment as of 2023)

Table 18. Global Herpes Zoster Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Herpes Zoster Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Herpes Zoster Treatment, Headquarters and Area Served

Table 21. Global Key Players of Herpes Zoster Treatment, Product and Application

Table 22. Global Key Players of Herpes Zoster Treatment, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Herpes Zoster Treatment Revenue Market Share by Type (2019-2024)

Table 26. Global Herpes Zoster Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Herpes Zoster Treatment Revenue Market Share by Type (2025-2030)

Table 28. Global Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Herpes Zoster Treatment Revenue Share by Application (2019-2024)

Table 30. Global Herpes Zoster Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Herpes Zoster Treatment Revenue Share by Application (2025-2030)

Table 32. North America Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Herpes Zoster Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Herpes Zoster Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Herpes Zoster Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Herpes Zoster Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Herpes Zoster Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Herpes Zoster Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Herpes Zoster Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Herpes Zoster Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Herpes Zoster Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Herpes Zoster Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Herpes Zoster Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Herpes Zoster Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Herpes Zoster Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Herpes Zoster Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Herpes Zoster Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Herpes Zoster Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Herpes Zoster Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Herpes Zoster Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 64. Roche Company Details

Table 65. Roche Business Overview

Table 66. Roche Herpes Zoster Treatment Product

Table 67. Roche Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)

Table 68. Roche Recent Developments

Table 69. Novartis Company Details

Table 70. Novartis Business Overview

Table 71. Novartis Herpes Zoster Treatment Product

Table 72. Novartis Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)

Table 73. Novartis Recent Developments

Table 74. Merck Company Details

Table 75. Merck Business Overview

Table 76. Merck Herpes Zoster Treatment Product

Table 77. Merck Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)

Table 78. Merck Recent Developments

Table 79. GlaxoSmithKline Company Details

Table 80. GlaxoSmithKline Business Overview

Table 81. GlaxoSmithKline Herpes Zoster Treatment Product

Table 82. GlaxoSmithKline Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)

Table 83. GlaxoSmithKline Recent Developments

Table 84. Abbott Laboratories Company Details

Table 85. Abbott Laboratories Business Overview

Table 86. Abbott Laboratories Herpes Zoster Treatment Product

Table 87. Abbott Laboratories Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)

Table 88. Abbott Laboratories Recent Developments

Table 89. Astellas Pharma Company Details

Table 90. Astellas Pharma Business Overview

Table 91. Astellas Pharma Herpes Zoster Treatment Product

Table 92. Astellas Pharma Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)

Table 93. Astellas Pharma Recent Developments

Table 94. Bausch Health Companies Company Details

Table 95. Bausch Health Companies Business Overview

Table 96. Bausch Health Companies Herpes Zoster Treatment Product

Table 97. Bausch Health Companies Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)

Table 98. Bausch Health Companies Recent Developments

Table 99. Teva Pharmaceutical Company Details

Table 100. Teva Pharmaceutical Business Overview

Table 101. Teva Pharmaceutical Herpes Zoster Treatment Product

Table 102. Teva Pharmaceutical Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)

Table 103. Teva Pharmaceutical Recent Developments

Table 104. Foamix Pharmaceuticals Company Details

Table 105. Foamix Pharmaceuticals Business Overview

Table 106. Foamix Pharmaceuticals Herpes Zoster Treatment Product

Table 107. Foamix Pharmaceuticals Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)

Table 108. Foamix Pharmaceuticals Recent Developments

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Herpes Zoster Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Herpes Zoster Treatment Market Share by Type: 2023 VS 2030

Figure 3. Oral Features

Figure 4. Topical Features

Figure 5. Others Features

Figure 6. Global Herpes Zoster Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Herpes Zoster Treatment Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Home Care Settings Case Studies

Figure 11. Herpes Zoster Treatment Report Years Considered

Figure 12. Global Herpes Zoster Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Herpes Zoster Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Herpes Zoster Treatment Market Share by Region: 2023 VS 2030

Figure 15. Global Herpes Zoster Treatment Market Share by Players in 2023

Figure 16. Global Top Herpes Zoster Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoster Treatment as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Herpes Zoster Treatment Revenue in 2023

Figure 18. North America Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Herpes Zoster Treatment Market Share by Type (2019-2030)

Figure 20. North America Herpes Zoster Treatment Market Share by Application (2019-2030)

Figure 21. North America Herpes Zoster Treatment Market Share by Country (2019-2030)

Figure 22. United States Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Herpes Zoster Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Herpes Zoster Treatment Market Share by Type (2019-2030)

Figure 26. Europe Herpes Zoster Treatment Market Share by Application (2019-2030)

Figure 27. Europe Herpes Zoster Treatment Market Share by Country (2019-2030)

Figure 28. Germany Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Herpes Zoster Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Herpes Zoster Treatment Market Share by Type (2019-2030)

Figure 36. China Herpes Zoster Treatment Market Share by Application (2019-2030)

Figure 37. Asia Herpes Zoster Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Herpes Zoster Treatment Market Share by Type (2019-2030)

Figure 39. Asia Herpes Zoster Treatment Market Share by Application (2019-2030)

Figure 40. Asia Herpes Zoster Treatment Market Share by Region (2019-2030)

Figure 41. Japan Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Share by Country (2019-2030)

Figure 51. Brazil Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Roche Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)

Figure 58. Novartis Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)

Figure 59. Merck Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)

Figure 60. GlaxoSmithKline Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)

Figure 61. Abbott Laboratories Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)

Figure 62. Astellas Pharma Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)

Figure 63. Bausch Health Companies Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)

Figure 64. Teva Pharmaceutical Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)

Figure 65. Foamix Pharmaceuticals Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions